Clinical trial
TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence - Patient Satisfaction and Complications of the Treatment
NCT02538991 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence - Patient Satisfaction and Complications of the Treatment
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2015
- Completion date
- December 31, 2024
- Enrollment
- 224 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
urinary stress incontinence